Overview of the MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to ...

Fetal Focus uses non-invasive prenatal testing to detect key genetic conditions without needing the father’s DNA, keeping ...

Rabin Medical Center researcher says current standard for testing hereditary disease risk doesn’t account for Jews and other ...

Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

As intentional motherhood becomes the norm, a new demographic shift is quietly reshaping maternal care, fertility ...

Myriad Genetics posted Q2 revenue growth of 1% year-over-year, but adjusted for one-time events, growth would have been 5%.

Genetic testing company Natera (NASDAQ:NTRA). reported Q2 CY2025 results topping the market’s revenue expectations, with ...

Senate Democrats have demonstrated this summer that they have not abandoned their crusade to force American taxpayers to fund ...

Revenue (GAAP) jumped 32.2% year over year to $546.6 million in Q2 2025, beating GAAP revenue estimates by 14.8%. Loss per share (GAAP) came in at $ (0.74), missing expectations due to legal and ...

Scientists in Japan have used CRISPR gene-editing technology to remove the extra chromosome that causes Down syndrome.